Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 1060

Results For "RI"

10747 News Found

Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg
News | June 02, 2021

Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg

The Banzel Tablets, 200 mg and 400 mg market2 achieved annual sales of approximately $285.3 million.


Shilpa Medicare Q4FY21 consolidated PAT at Rs. 7.82 Cr
News | June 01, 2021

Shilpa Medicare Q4FY21 consolidated PAT at Rs. 7.82 Cr

The company has posted net profit of Rs.147.78 crores for the 12 months period ended March 31, 2021


Marksans Pharma Q4 FY21 profit up 86%
News | June 01, 2021

Marksans Pharma Q4 FY21 profit up 86%

The company's operating revenue for Q4 FY21 was Rs. 330.2 crore


Unilever to launch recyclable tubes for oral care in India
Packaging | June 01, 2021

Unilever to launch recyclable tubes for oral care in India

EPL will supply APR approved 100% recyclable and fully sustainable Platina Tubes for the toothpaste category of Unilever


Aurobindo Pharma Q4FY21 consolidated net profit at Rs. 801.58 Cr
News | May 31, 2021

Aurobindo Pharma Q4FY21 consolidated net profit at Rs. 801.58 Cr

The company reported total income of Rs.24774.63 crores during the 12 months period ended March 31, 2021


Govt. to give 12 Cr COVID vaccine doses in June 2021
News | May 31, 2021

Govt. to give 12 Cr COVID vaccine doses in June 2021

7.94 crore doses were made available to the states in May 2021


IPCA Q4FY21 consolidated net profit slides QoQ to Rs. 161.34 Cr
News | May 29, 2021

IPCA Q4FY21 consolidated net profit slides QoQ to Rs. 161.34 Cr

The company has posted net profit of Rs.1140.01 crores during FY 2020-21


Zydus new initiative to safeguard patients against counterfeit drugs
News | May 29, 2021

Zydus new initiative to safeguard patients against counterfeit drugs

The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website


Shilpa Medicare Jadcherla facility gets GMP certification from Russia
Policy | May 29, 2021

Shilpa Medicare Jadcherla facility gets GMP certification from Russia

The GMP certificate is valid for three years until April 2024.


SMS Pharmaceuticals posts Q4FY21 consolidated PAT of Rs. 22.21 Cr
News | May 29, 2021

SMS Pharmaceuticals posts Q4FY21 consolidated PAT of Rs. 22.21 Cr

It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021